“Three new lung tumor subtypes identified in DNA profiling study” 
(Nov 1) innovations report reports, “A new study has identified three subtypes of non-small-cell lung cancer tumors, a finding that may provide valuable clinical information about patient survival in early- or late-stage disease, how likely the cancer is to spread and whether the tumor will prove resistant to chemotherapy.”
“Genetic 'link' to cot deaths”
(Nov 1) Daily Mail reports, “Scientists in the US say they have found the strongest evidence yet that cot death is caused partly by a genetic disorder, which may one day be treatable.”
“Viral Genetics' AIDS Study Results to Be Presented at Institute of Human Virology's 2006 International Meeting”
(Oct 31) Medical News Today reports, “The results of Viral Genetics' (OTC Bulletin Board: VRAL - News) recent AIDS study of VGV-1 in South Africa will be presented at the Institute of Human Virology's (IHV) 2006 Annual International Meeting on November 17 in Baltimore, Maryland.”
“Gene Therapy Appears To Reduce Symptoms Of Parkinson's By 40 Percent”
(Oct 30) Science Daily reports, “Ceregene, Inc., has announced that CERE-120, a gene therapy product in development for the treatment of Parkinson’s disease, was well tolerated and appeared to reduce symptoms by approximately 40% (p<0.001), as measured by the Unified Parkinson’s Disease Rating Scale (UPDRS) motor “off” score, in an open-label Phase 1 study in 12 patients with advanced disease.”
“Genetic 'breakthough' offers hope to schizophrenia victims”
(Oct 30) Guardian Unlimited reports, “Scientists have discovered a variation in a gene in people at risk of schizophrenia that strongly suggests they will develop the condition.”
“454 Sequencing™ Reveals New Pathway In RNA Interference”
(Oct 30) Medical News Today reports, “CuraGen Corporation's majority-owned subsidiary 454 Life Sciences today announced that research on small RNAs, conducted by Cold Spring Harbor Laboratory, has revealed the dual role of the ARGONAUTE 4 protein (AGO4) in RNA-directed DNA methylation.”
“Finding Genomic Elements involved in Human Disease with a New Approach”
(Oct 29) www.uni-protokolle.de reports, “With their new approach, the bioformatics expert and systems biologist Professor Nikolaus Rajewsky from the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Dr. Kevin Chen from the Center for Comparative Functional Genomics, New York University, New York (USA) are now able to look more systematically for structures in the human genome which are likely to be deleterious and are the causes of human disease.”
“Towards a Global Map of Epigenetic Variation”
(Oct 29) UK Bioinformatics Forum reports, “A new DNA map, published in Nature Genetics today, provides the first large-scale study of biological inheritance in human that is not DNA-sequence based.”
“Experts crack cancer 'gene codes'”
(Oct 28) BBC News reports, “US scientists have cracked the entire genetic code of breast and colon cancers, offering new treatment hopes.”
“Let's Divide: How Daughter Cells Get Their Share Of Genetic Material”
(Oct 28) Science Daily reports, “When cells divide, control mechanisms ensure that the genetic material, in other words the chromosomes, is correctly distributed to the daughter cells.”
“International Conference on Tularemia to be held in Woods Hole”
(Oct 27) EurekAlert! reports, “Scientists who study the bacterium Francisella tularensis, and the illness it causes, tularemia, will be meeting next week at the MBL (Marine Biological Laboratory) for the Fifth International Conference on Tularemia.”
“Gene Could Point to Crohn's, Colitis Treatments”
(last accessed 2/2008)
(Oct 26) Hon News reports, “A newly discovered gene may help protect carriers against Crohn's disease and colitis, inflammatory bowel diseases (IBDs) that affect an estimated one million Americans, researchers say.”
|